Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
about
Pleiotropic effects of statins in the diseases of the liverNew advances in hepatocellular carcinomaAssociation between hepatitis B and metabolic syndrome: Current state of the artNutrition and metabolism in hepatocellular carcinomaLipid-lowering agents in the management of nonalcoholic fatty liver diseaseNonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Post-ischemic stroke rehabilitation is associated with a higher risk of fractures in older women: A population-based cohort study.Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population.A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in TaiwanAssociation between metabolic factors and chronic hepatitis B virus infection.Statins intake and risk of liver cancer: A dose-response meta analysis of prospective cohort studiesStatin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score.Statin use and risk of liver cancer: an update meta-analysis.Review article: prescribing medications in patients with cirrhosis - a practical guide.The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.Statin use in patients with cirrhosis: a retrospective cohort study.Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan.Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across TaiwanEffects of statins on the risk of hepatocellular carcinomaChemopreventive strategies in hepatocellular carcinomaStatin use and risk of primary liver cancer in the Clinical Practice Research Datalink.Use of 5-alpha-reductase inhibitors did not increase the risk of cardiovascular diseases in patients with benign prostate hyperplasia: a five-year follow-up study.Chemically induced mouse liver tumors are resistant to treatment with atorvastatin.Systematic review with network meta-analysis: statins and risk of hepatocellular carcinomaStatins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort studyImproved understanding of risk factors could help to reduce the incidence of hepatocellular carcinomaIncreasing Receipt of High-Tech/High-Cost Imaging and Its Determinants in the Last Month of Taiwanese Patients With Metastatic Cancer, 2001-2010: A Retrospective Cohort Study.Statin-Based Palliative Therapy for Hepatocellular CarcinomaImpact of acetylcholinesterase inhibitors on the occurrence of acute coronary syndrome in patients with dementia.Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptideRisk of cancer among patients with herpes zoster infection: a population-based study.Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesReceipt of Life-Sustaining Treatments for Taiwanese Pediatric Patients Who Died of Cancer in 2001 to 2010: A Retrospective Cohort Study.Meta-analysis of studies using statins as a reducer for primary liver cancer risk.Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementiaStatins are Associated With a Reduced Risk of Brain Cancer: A Population-Based Case-Control Study.
P2860
Q26741176-70346309-E53B-4DC0-B15F-103422CEF867Q26749329-B0991E51-A131-4427-B110-09189F25BE17Q26772343-D943C45B-3A09-41A7-8A42-49EB97574E30Q26862862-53B0213E-6891-4C0D-AD8A-CC741A553F9AQ27024352-07B27FAD-B9DA-43D9-A4D7-B4F1CE1A7E93Q30234736-3AD2C72F-6384-4709-878D-A6C76132451CQ33570864-F3BF141C-D157-4679-98A5-64C9FEB0F533Q33612306-266BB123-FAF6-414B-8953-9563631DFDD4Q33641136-C40B67B6-40B2-4256-A25B-D13D7C6BE4DAQ33780113-1E7F0A7D-5877-4C5F-8E04-17F0275EA590Q33885894-0E24FB74-9852-4164-A502-B12E59060F37Q33984012-43C116B1-5108-4AE4-A7AA-A2E585FCD29CQ34198230-51DB23C0-CC47-450D-8455-06EFEF957CECQ34342554-9ECCAF17-B9FF-4D62-8791-ACB894966BF1Q34363241-6176330A-C87C-48A2-AACC-59DFCBB78877Q34661975-FA73BCA3-5D14-4A7E-BAEA-52DC2122E857Q34935503-33548369-151F-426C-8666-FC7BBD7A827AQ34980383-BC2D215D-1CBD-4345-834F-A3434875B340Q34997752-6E65C0CD-4C78-450D-8455-DA14D0390141Q35101365-2676AAAE-397F-491D-B04F-ABAEA5D231EBQ35152907-2BB38853-FCE2-4A45-9D7C-49865836F100Q35213928-FE44D2EF-11DC-4C99-AA52-C0CA8CD539B5Q35335391-9BE5BB06-1891-43F6-AB06-1F99A1A9C0A3Q35946029-83F85D9D-7DB4-44C3-A5D2-832148B9A5CCQ36125495-664547B6-17AB-48F6-84A5-79FD9A74C140Q36152361-D5A213D2-9C47-43BA-8284-29976021053FQ36154129-CC8D8D7D-7C09-44CD-A56A-0778E84B013AQ36179905-FF76829F-8CC1-46C2-92A7-EFFCA7F6BEE0Q36195119-FF63E07B-CCBC-4334-B631-A67359D99235Q36206887-068980F4-5351-4BC3-A399-31A4A0E8E3C9Q36291488-228BED14-C359-4AA7-B1E4-A81F6BEE326CQ36305699-7EFC963C-B8DB-453A-8BA1-B95265F3074FQ36338920-9A29364D-000A-454F-9344-62F97BEE12DFQ36444733-085BA0C3-4888-4FF1-B67E-8210F9AC8970Q36461735-8A43C261-51FC-43A4-9EBC-0C0DC8679223Q36561567-06A125BA-0001-43BD-9962-F724FB5D3839Q36838141-65227A85-98A8-481E-8382-ADC253DE34F5Q36919251-3948C984-4E21-4F7A-95BC-5AEAC566E0B0Q37063986-FF155808-026B-4EA2-804D-42A439A06564Q37206323-62AAA26D-94B5-45A0-B3F5-6B511F5DA7A6
P2860
Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Statins and the risk of hepato ...... h hepatitis B virus infection.
@en
Statins and the risk of hepato ...... h hepatitis B virus infection.
@nl
type
label
Statins and the risk of hepato ...... h hepatitis B virus infection.
@en
Statins and the risk of hepato ...... h hepatitis B virus infection.
@nl
prefLabel
Statins and the risk of hepato ...... h hepatitis B virus infection.
@en
Statins and the risk of hepato ...... h hepatitis B virus infection.
@nl
P2093
P356
P1476
Statins and the risk of hepato ...... h hepatitis B virus infection.
@en
P2093
Chang-Hsing Lee
Jung-Der Wang
Yu-Tse Tsan
P304
P356
10.1200/JCO.2011.36.0917
P407
P577
2012-01-23T00:00:00Z